Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on June 5, 2026

Jun. 5, 2026

Memo Therapeutics AG Presents Further Analyses of the Phase II Trial Results of Potravitug for the Treatment of BKPyV Infection in Kidney Transplant Recipients in an Oral Presentation at the 63rd European Renal Association Congress

Indeterminate GlobeNewswire

Jun. 5, 2026

Victoire : Un projet de loi vise à encadrer la vente des boissons énergisantes caféinées aux jeunes de 16 ans et moins

Indeterminate GlobeNewswire

Jun. 5, 2026

Chemiluminescence Immunoassay Market Expected to Reach USD 16.39 Billion by 2031 | MarketsandMarkets™

Indeterminate GlobeNewswire

Jun. 5, 2026

Graphene Heating Films Market worth $1.51 billion by 2030, at 8.1%, says MarketsandMarkets™

Indeterminate GlobeNewswire

Jun. 5, 2026

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Indeterminate GlobeNewswire

Jun. 5, 2026

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

Indeterminate GlobeNewswire

Jun. 5, 2026

ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network

Indeterminate GlobeNewswire

Jun. 5, 2026

WORK Medical Technology Group Participated in 2026 CBA-China Annual Conference

Indeterminate GlobeNewswire

Jun. 5, 2026

Global Norovirus Outbreaks, Ebola Emergency and Rising Disease Threats Highlight Growing Need for TOMI Environmental Solutions' SteraMist Technology

Indeterminate GlobeNewswire

Jun. 5, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.

Indeterminate GlobeNewswire

Jun. 5, 2026

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

Indeterminate GlobeNewswire

Jun. 5, 2026

Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™

Indeterminate GlobeNewswire

Jun. 5, 2026

Independent Market Research Finds Strong Physician Intent to Prescribe Moleculin's Annamycin in Relapsed/Refractory AML

Indeterminate GlobeNewswire

Jun. 5, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Eos SENOLYTIX Presents Best-in-Class Preclinical Body Composition Data Highlighting Unique Muscle Mass Gains with MitoXcel™ Geropeptide PTC-2105 at the Sachs 2nd Annual Obesity & Cardiometabolic Innovation Forum

Indeterminate GlobeNewswire

Jun. 5, 2026

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

Indeterminate GlobeNewswire

Jun. 5, 2026

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF

Indeterminate GlobeNewswire

Jun. 5, 2026

MISOORA Unveils Revolutionary K-Beauty Skincare Range Emphasizing Longevity Over Anti-Aging

Indeterminate GlobeNewswire